These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 33955079

  • 1. Extracorporeal photopheresis to attenuate decline in lung function due to refractory obstructive allograft dysfunction.
    EPI Study Group, Hage CA, Klesney-Tait J, Wille K, Arcasoy S, Yung G, Hertz M, Chan KM, Morrell M, Goldberg H, Vedantham S, Derfler MC, Commean P, Berman K, Spitznagel E, Atkinson J, Despotis G.
    Transfus Med; 2021 Aug; 31(4):292-302. PubMed ID: 33955079
    [Abstract] [Full Text] [Related]

  • 2. Factors Associated With Mortality and Response to Extracorporeal Photopheresis in Lung Allograft Recipients With Bronchiolitis Obliterans Syndrome.
    Karnes HE, Schindler EI, Morrell M, Hachem RR, Berman K, Vedantham S, Atkinson J, Spitznagel E, Despotis GJ.
    Transplantation; 2019 May; 103(5):1036-1042. PubMed ID: 30130331
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of extracorporeal photopheresis on lung function decline for severe bronchiolitis obliterans syndrome following allogeneic stem cell transplantation.
    Brownback KR, Simpson SQ, Pitts LR, Polineni D, McGuirk JP, Ganguly S, Aljitawi OS, Lin TL, Singh A, Abhyankar S.
    J Clin Apher; 2016 Aug; 31(4):347-52. PubMed ID: 26031713
    [Abstract] [Full Text] [Related]

  • 5. A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation.
    Jaksch P, Scheed A, Keplinger M, Ernst MB, Dani T, Just U, Nahavandi H, Klepetko W, Knobler R.
    J Heart Lung Transplant; 2012 Sep; 31(9):950-7. PubMed ID: 22884382
    [Abstract] [Full Text] [Related]

  • 6. Initiation of extracorporeal photopheresis in lung transplant patients with mild to moderate refractory BOS: A single-center real-life experience.
    Leroux J, Hirschi S, Essaydi A, Bohbot A, Degot T, Schuller A, Olland A, Kessler R, Renaud-Picard B.
    Respir Med Res; 2022 May; 81():100913. PubMed ID: 35525096
    [Abstract] [Full Text] [Related]

  • 7. Extracorporeal photopheresis after lung transplantation: a 10-year single-center experience.
    Benden C, Speich R, Hofbauer GF, Irani S, Eich-Wanger C, Russi EW, Weder W, Boehler A.
    Transplantation; 2008 Dec 15; 86(11):1625-7. PubMed ID: 19077900
    [Abstract] [Full Text] [Related]

  • 8. Cessation of extracorporeal photopheresis in chronic lung allograft dysfunction: effects on clinical outcome in adults.
    Robinson CA, Huber L, Murer C, Schuurmans M, Kohler M, Hofbauer G, Benden C.
    Swiss Med Wkly; 2017 Dec 15; 147():w14429. PubMed ID: 28488260
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome without Significantly Impacting Measured Pulmonary Functions.
    Hefazi M, Langer KJ, Khera N, Adamski J, Roy V, Winters JL, Gastineau DA, Jacob EK, Kreuter JD, Gandhi MJ, Hogan WJ, Litzow MR, Hashmi SK, Yadav H, Iyer VN, Scott JP, Wylam ME, Cartin-Ceba R, Patnaik MM.
    Biol Blood Marrow Transplant; 2018 Sep 15; 24(9):1906-1913. PubMed ID: 29679771
    [Abstract] [Full Text] [Related]

  • 11. Lung transplant recipients on long-term extracorporeal photopheresis.
    Isenring B, Robinson C, Buergi U, Schuurmans MM, Kohler M, Huber LC, Benden C.
    Clin Transplant; 2017 Oct 15; 31(10):. PubMed ID: 28653398
    [Abstract] [Full Text] [Related]

  • 12. Extracorporeal Photopheresis for Bronchiolitis Obliterans Syndrome After Lung Transplantation.
    Hachem R, Corris P.
    Transplantation; 2018 Jul 15; 102(7):1059-1065. PubMed ID: 29557913
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome After Lung Transplantation.
    Pecoraro Y, Carillo C, Diso D, Mantovani S, Cimino G, De Giacomo T, Troiani P, Shafii M, Gherzi L, Amore D, Rendina EA, Venuta F, Anile M.
    Transplant Proc; 2017 May 15; 49(4):695-698. PubMed ID: 28457374
    [Abstract] [Full Text] [Related]

  • 14. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
    Benden C, Haughton M, Leonard S, Huber LC.
    J Heart Lung Transplant; 2017 Sep 15; 36(9):921-933. PubMed ID: 28662986
    [Abstract] [Full Text] [Related]

  • 15. Early extracorporeal photopheresis treatment is associated with better survival in patients with chronic or recurrent acute lung allograft dysfunction.
    Gautschi F, Vogelmann T, Ortmanns G, Knörr F, Steinack C, Hage R, Nägeli M, Schuurmans MM.
    J Clin Apher; 2024 Jun 15; 39(3):e22128. PubMed ID: 38829041
    [Abstract] [Full Text] [Related]

  • 16. Long-Term Off-Line Extracorporeal Photochemotherapy in Patients with Chronic Lung Allograft Rejection Not Responsive to Conventional Treatment: A 10-Year Single-Centre Analysis.
    Del Fante C, Scudeller L, Oggionni T, Viarengo G, Cemmi F, Morosini M, Cascina A, Meloni F, Perotti C.
    Respiration; 2015 Jun 15; 90(2):118-28. PubMed ID: 26112178
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.